Recommended Vitamin D3 Dosing for Adults
For most adults under age 75, follow the Institute of Medicine's Recommended Daily Allowance of 600 IU daily (ages 18-70) or 800 IU daily (over age 70), as empiric supplementation beyond these amounts is not recommended for disease prevention in the general population 1.
Age-Based Dosing Algorithm
Children and Adolescents (1-18 years)
- Recommended dose: 1200 IU daily (weighted average from clinical trials)
- Rationale: Prevents nutritional rickets and may reduce respiratory tract infections 1
- Can be achieved through fortified foods, multivitamins, or dedicated supplements
Adults Under 50 Years
- Recommended dose: 600 IU daily (IOM standard)
- Do NOT supplement beyond this amount empirically 1
Adults 50-74 Years
- Recommended dose: 600 IU daily (ages 50-70) or 800 IU daily (over 70)
- Do NOT routinely test 25(OH)D levels or supplement beyond these amounts 1
Adults ≥75 Years
- Recommended dose: 800 IU daily minimum, consider empiric supplementation
- Rationale: Potential mortality reduction benefit in this age group 1
Pregnancy
- Recommended dose: Empiric supplementation advised (specific dose not defined in guidelines, but prenatal vitamins typically contain 400-1000 IU)
- Use daily lower-dose rather than intermittent high-dose regimens
- Benefits include reduced pre-eclampsia, preterm birth, and neonatal mortality 1
Adjustments for Special Populations
Obesity (BMI ≥30 kg/m²)
Higher doses are required due to volumetric dilution and sequestration in adipose tissue:
- Maintenance dose: 125 IU/kg/m² daily (rather than standard 2000 IU) 2
- Alternative regimen: 7000 IU daily or 30,000 IU weekly for prolonged maintenance 3
- Treatment of deficiency: 50,000 IU weekly for 6-8 weeks, then higher maintenance 3
The standard 2000 IU daily dose is insufficient in obese patients—one study showed levels dropping back to 22.8 ng/mL at 6 months with standard dosing versus maintaining 34 ng/mL with BMI-adjusted dosing 2.
Malabsorption Syndromes (Crohn's, celiac, bariatric surgery, chronic pancreatitis)
- Maintenance dose: 7000 IU daily or 30,000 IU weekly 3
- Treatment of deficiency: 30,000 IU twice weekly or 50,000 IU weekly for 6-8 weeks 3
- Monitor response as absorption is unpredictable
Liver Disease (Cirrhosis, chronic hepatitis)
- Maintenance dose: 7000 IU daily or 30,000 IU weekly 3
- Treatment of deficiency: 30,000 IU twice weekly or 50,000 IU weekly for 6-8 weeks 3
- Impaired 25-hydroxylation requires higher doses
Medications Affecting Vitamin D Metabolism
For patients on these medications, use higher maintenance doses:
- Anticonvulsants (phenytoin, carbamazepine, phenobarbital)
- Glucocorticoids
- Antiretrovirals
- Antifungals (ketoconazole)
- Weight loss medications (orlistat)
Recommended approach: 7000 IU daily or 30,000 IU weekly for maintenance 3
Treatment of Established Deficiency
When 25(OH)D is documented <20 ng/mL:
Standard Approach
- Loading dose: 50,000 IU weekly for 6-8 weeks 2
- Then maintenance: Adjust based on patient factors above
High-Risk Patients (obesity, malabsorption, liver disease)
- Loading dose: 50,000 IU weekly OR 30,000 IU twice weekly for 6-8 weeks 3
- Then maintenance: 7000 IU daily or 30,000 IU weekly 3
Critical Caveats
Avoid intermittent high-dose regimens for general prevention—daily or weekly dosing is preferred over monthly or less frequent high doses, as intermittent dosing may paradoxically increase falls and fractures 1, 4.
Do not routinely screen healthy adults aged 50-74—the 2024 Endocrine Society guidelines explicitly recommend against routine 25(OH)D testing in this population, as outcome-specific benefits from testing have not been established 1.
The "vitamin D paradox"—while observational studies link low vitamin D to numerous diseases, most large RCTs in vitamin D-replete populations show no benefit 4. Benefits are primarily seen when correcting actual deficiency (particularly <12 ng/mL or 30 nmol/L) 4.
Predictive dosing equation exists for calculating individualized doses based on starting 25(OH)D, age, BMI, and albumin 5, but for practical purposes, the algorithms above suffice for most clinical scenarios.
Safety margin—doses up to 4000-7000 IU daily have been studied for years without significant safety concerns 6, 3, 7, providing reassurance for higher dosing in appropriate populations.